President threatens action if manufacturers don’t agree to “most-favored-nation” pricing for American patients

The Trump administration has issued a directive to major pharmaceutical companies, urging them to lower the prices of prescription drugs in the U.S. to match the lowest prices offered in other developed nations. In letters sent to 17 drug manufacturers, the President outlined a series of steps the companies must take to avoid potential government action.

The letters, sent to companies including Pfizer, Johnson & Johnson, and Merck, call on manufacturers to provide these “most-favored-nation” (MFN) prices to all Medicaid patients. The administration is also requiring manufacturers to agree not to offer better prices for new drugs to other developed nations than those offered in

See Full Page